Notes in 🔹 Pneumologie

To Subscribe, use this Key

Status	Last Update	Fields
Published	01/25/2025	Kreislauf im Schlaf
Published	01/25/2025	OSAS
Published	01/25/2025	CSA
Published	01/25/2025	Schlafapnoe Screening
Published	01/25/2025	Schweregrade Apnoe
Published	01/25/2025	Risikofaktoren Schlafapnoe
Published	01/25/2025	OSAS Therapie
Published	01/25/2025	Obesitas - Hypoventilation
Published	01/25/2025	Obstruktive Ventilationsstörung
Published	01/25/2025	COPD Definition
Published	01/25/2025	Emphysemmuster nach Simon (Pink Puffer)
Published	01/25/2025	Asthma vs COPD Unterschiede
Published	01/25/2025	COPD Spirometrie Diagnostik
Published	01/25/2025	GOLD ABE Assessment
Published	01/25/2025	mMRC Dyspnea Scale
Published	01/25/2025	CAT COPD
Published	01/25/2025	COPD Therapie
Published	01/25/2025	LTx häufigste Empfängerdiagnosen
Published	01/25/2025	Lung Allocation Score bei LTx
Published	01/25/2025	Absolute Kontraindikationen der LTx
Published	01/25/2025	Immunsuppressive Therapie nach LTx
Published	01/25/2025	Perioperative Antiinfektiva bei LTx
Published	01/25/2025	Akute Transplantatabstoßung LTx
Published	01/25/2025	Chronic Lung Allograft Dysfunction CLAD
Published	01/25/2025	Einteilung Chronic Lung Allograft Dysfunction CLAD
Published	01/25/2025	Risikofaktoren für Lungenkarzinom
Published	01/25/2025	Häufigkeit Lungenkarzinom-Typen
Published	01/25/2025	Stadieneinteilung beim Lungenkarzinom
Published	01/25/2025	IASLC Stadien (Internat Assoc for the study of Lung Ca)
Published	01/25/2025	primäre Resektion eines Lungenkarzinoms bei welchen IASLC Stadien?
Published	01/25/2025	Molekular gezielte Therapien bei welchem IASLC Stadium?
Published	01/25/2025	“Oligo Metastatic Disease” OMD-Konzept beim Lungenkarzinom
Published	01/25/2025	Diagnostik bei Lungenkarzinom
Published	01/25/2025	Was beachten bei Tumorbiopsie Lunge
Published	01/25/2025	Virtuelle Bronchoskopische Navigation bei Lungenkarzinom-Diagnostik
Published	01/25/2025	Diagnostik Lymphknotenstaging bei Lungenkarzinom
Published	01/25/2025	Lungenkarzinom Stadiengerechte Therapie
Published	01/25/2025	Bestimmung der Operabilität eines Lungenkarzinoms
Published	01/25/2025	Chirurgische Behandlung Lungenkarzinom
Published	01/25/2025	Palliative Therapie Lungenkarzinom
Published	01/25/2025	Infektiöse Todesursache Nr 1
Published	01/25/2025	Erregerspektrum bei Pneumonie
Published	01/25/2025	Pneumonie Untersuchungsbefund
Published	01/25/2025	Diagnostik Pneumonie
Published	01/25/2025	Röntgenbefund
Published	01/25/2025	Röntgenbefund
Published	01/25/2025	Röntgenbefund
Published	01/25/2025	Ambulante Risikoabschätzung bei V.a. Pneumonie
Published	01/25/2025	Risikoabschätzung intensivmedizinischer Therapienotwendigkeit der Pneumonie
Published	01/25/2025	Einteilung Pneumonie nach klinischem Verlauf
Published	01/25/2025	initiale Antibiotikatherapie bei ambulanter Pneumonie
Published	01/25/2025	Wann liegt der Verdacht auf Pseudomonas bei einer Pneumonie vor?
Published	01/25/2025	Therapie der Pneumonie bei Verdacht auf nosokomiale Erreger
Published	01/25/2025	Pneumonie Antibiotikatherapie im Verlauf
Published	01/25/2025	Diagnostik Pneumonie-begleitender Pleuraerguss
Published	01/25/2025	Risikofaktoren für Pneumonie-begleitenden Pleuraerguss
Published	01/25/2025	Einteilung Pneumonie-begleitenden Pleuraerguss
Published	01/25/2025	parapneumonisches Pleuraempyem Therapie
Published	01/25/2025	Definitionen Pneumonie
Published	01/25/2025	Diagnosekriterien HAP
Published	01/25/2025	DD Pneumonie
Published	01/25/2025	CT Befund bei Tbc
Published	01/25/2025	Mikroskopie Befund bei Tbc
Published	01/25/2025	Tbc Symptome
Published	01/25/2025	Tbc Risikofaktoren
Published	01/25/2025	Mendel-Mantoux-Test
Published	01/25/2025	IGRA Tbc
Published	01/25/2025	Diagnostik Tbc
Published	01/25/2025	DD Tuberkulose
Published	01/25/2025	Tbc Verlaufsformen
Published	01/25/2025	Tuberkulöser Primärkomplex
Published	01/25/2025	Kavernöse Lungentuberkulose
Published	01/25/2025	Extrapulmonale Tuberkulose ()
Published	01/25/2025	Miliartuberkulose
Published	01/25/2025	Tbc Therapie
Published	01/25/2025	Nebenwirkungen Tbc Therapeutika
Published	01/25/2025	MDR Tbc Resistenzen
Published	01/25/2025	Sarkoidose Pathogenese
Published	01/25/2025	häufigste Organbeteiligungen bei Sarkoidose
Published	01/25/2025	Löfgren Syndrom
Published	01/25/2025	Stadieneinteilung Sarkoidose
Published	01/25/2025	Sarkoidose Remission nach Stadien
Published	01/25/2025	DD Sarkoidose
Published	01/25/2025	Sarkoidose CT Befund
Published	01/25/2025	Sarkoidose Therapieindikationen
Published	01/25/2025	Sarkoidose Therapie
Published	01/25/2025	Granulomatöse Lungenerkrankungen
Published	01/25/2025	Granulomatose mit Polyangiitis
Published	01/25/2025	Diagnostischer Marker für GPA (Granulomatose mit Polyangiitis)
Published	01/25/2025	Diagnostische Kriterien für GPA
Published	01/25/2025	GPA Röntgen Befund
Published	01/25/2025	GPA Therapie
Published	01/25/2025	EGPA klinischer Trias
Published	01/25/2025	EGPA histologischer Trias
Published	01/25/2025	EGPA Verlaufsformen
Published	01/25/2025	EGPA Labor
Published	01/25/2025	Asthma bronchiale Diagnosekriterien
Published	01/25/2025	Asthma Therapie bei Exazerbation
Published	01/25/2025	Emphysemmuster nach Thurlbeck (Blue Bloater)
Published	01/25/2025	Asthma Symptome
Published	01/25/2025	Asthma im Verlauf
Published	01/25/2025	Asthma DD
Published	01/25/2025	Primäre Pleuraerkrankungen
Published	01/25/2025	Sekundäre Pleuraerkankungen
Published	01/25/2025	Pleuritis Untersuchungsbefund
Published	01/25/2025	Ursachen für Pleuritis
Published	01/25/2025	Pleuraerguss Definition
Published	01/25/2025	Pleuraerguss Ursachen
Published	01/25/2025	Pleuraerguss Untersuchungsbefund
Published	01/25/2025	Pleuraerguss Röntgendiagnostik, Sonderformen
Published	01/25/2025	Pleuraerguss Bildgebung
Published	01/25/2025	Exsudat Kriterien
Published	01/25/2025	Transsudat vs Exsudat
Published	01/25/2025	Pleuraerguss Zytologie
Published	01/25/2025	Punktion Pleuraerguss
Published	01/25/2025	Pleuraerguss Therapie
Published	01/25/2025	Pleuraempyem Ursachen
Published	01/25/2025	Risikopatienten Pleuraempyem
Published	01/25/2025	Pleuraempyem häufigste Erreger
Published	01/25/2025	Bedeutung pH Wert bei Pleuraempyem
Published	01/25/2025	Pleuraempyem Bildgebung
Published	01/25/2025	Einteilung Pleuraempyem
Published	01/25/2025	Stadien Pleuraempyem
Published	01/25/2025	Pleuraempyem Therapie
Published	01/25/2025	Pleuraempyem Komplikationen
Published	01/25/2025	Pneumothorax Definition
Published	01/25/2025	Traumatischer Pneumothorax
Published	01/25/2025	Pneumothorax Untersuchungsbefund
Published	01/25/2025	Spannungspneumothorax
Published	01/25/2025	Pneumothorax Diagnostik
Published	01/25/2025	Pneumothorax Therapie
Published	01/25/2025	Positionen für Thoraxdrainage bei Pneumothorax
Published	01/25/2025	Pleura Plaques
Published	01/25/2025	Pleura Tumore
Published	01/25/2025	MPM Malignes Pleuramesotheliom
Published	01/25/2025	MPM Diagnostik
Published	01/25/2025	MPM Histologie
Published	01/25/2025	MPM Therapie
Published	01/25/2025	Lungenfibrose Definition
Published	01/25/2025	Kategorien Lungenparenchymerkrankungen
Published	01/25/2025	UIP Usual interstitial pneumonia Muster Histopathologie
Published	01/25/2025	UIP Usual interstitial pneumonia Muster im CT 👨‍🌾
Published	01/25/2025	UIP Muster: mögliche zugrundeliegenden Erkrankungen
Published	01/25/2025	IPF Idiopathische pulmonale Fibrose
Published	01/25/2025	IPF Pathogenese
Published	01/25/2025	IPF Diagnose
Published	01/25/2025	Bronchoalveoläre Lavage bei Lungenfibrose
Published	01/25/2025	IPF Antifibrotische Therapie
Published	01/25/2025	NSIP Non specific Interstitial Pneumonia Muster Histopathologie
Published	01/25/2025	NSIP Non specific Interstitial Pneumonia Muster CT
Published	01/25/2025	NSIP mögliche zugrundeliegenden Erkrankungen
Published	01/25/2025	EAA Exogen allergische Alveolitis
Published	01/25/2025	EAA Symptome
Published	01/25/2025	EAA Behandlungsprinzipien
Published	01/25/2025	Pulmonale Manifestation der rheumatoiden Arthritis
Published	01/25/2025	SSc Therapie
Status	Last Update	Fields